Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Biotricity Inc. (OTC: BTCY).

Full DD Report for BTCY

You must become a subscriber to view this report.


Recent News from (OTC: BTCY)

Biotricity Developing ECG Patch for Anticipated Q1 2019 Release
REDWOOD CITY, Calif., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Biotricity Inc.  (OTCQB: BTCY ), a medical diagnostic and consumer healthcare technology company, today announced that it is developing “Biopatch,” an ECG patch which it hopes to release in Q1 2019. An extension...
Source: GlobeNewswire
Date: September, 05 2018 08:00
Biotricity Issues Statement Regarding Recent Promotional Activity
REDWOOD CITY, Calif., Aug. 24, 2018 (GLOBE NEWSWIRE) -- Biotricity, Inc. (OTCQB:BTCY) (the “Company”) announced today that it has been made aware of and requested by the OTC Markets Group, Inc. to comment on recent promotional activity concerning its common stock. On August...
Source: GlobeNewswire
Date: August, 24 2018 16:55
Biotricity Expands Salesforce to Cover Key US Markets and Begins Advisory Board Expansion to Move Into Preemptive Heart Disease Diagnostics
REDWOOD CITY, Calif., Aug. 21, 2018 (GLOBE NEWSWIRE) -- Biotricity Inc.  (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, has expanded its sales team to cover two additional geographic centers in the US that are key to driving faster adoption of its flag...
Source: GlobeNewswire
Date: August, 21 2018 08:00
Biotricity Completes Alpha Version of Deep Data Diagnostic Solution
REDWOOD CITY, Calif., July 24, 2018 (GLOBE NEWSWIRE) -- Biotricity Inc.  (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring solutions, has completed the alpha version of Bioflux 2.0’s dee...
Source: GlobeNewswire
Date: July, 24 2018 08:00
Biotricity Provides Fiscal 2018 First Quarter Updates for Shareholders
REDWOOD CITY, Calif., July 09, 2018 (GLOBE NEWSWIRE) -- Biotricity Inc.  (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring solutions, today provided operational updates for its fiscal 2018 firs...
Source: GlobeNewswire
Date: July, 09 2018 08:00
Biotricity's Bioflux Named Best Remote Patient Monitoring Solution by MedTech Breakthrough
REDWOOD CITY, Calif., June 06, 2018 (GLOBE NEWSWIRE) -- Biotricity Inc.  (OTCQB : BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring solutions, today announced that its Bioflux device has won the pre...
Source: GlobeNewswire
Date: June, 06 2018 08:00
Biotricity Achieves Revenue Generation and Market Expansion with Anchor Clients
REDWOOD CITY, Calif., May 31, 2018 (GLOBE NEWSWIRE) -- Biotricity Inc.  (OTCQB : BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring solutions, is pleased to announce market expansion across five states...
Source: GlobeNewswire
Date: May, 31 2018 08:00
San Antonio Endovascular & Heart Institute First to Deploy Biotricity's New Bioflux Remote Monitoring Device
REDWOOD CITY, Calif., April 23, 2018 (GLOBE NEWSWIRE) -- Biotricity Inc.  (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring solutions, today announced that the San Antonio Endovascular &...
Source: GlobeNewswire
Date: April, 23 2018 08:00
Biotricity Reviews Fiscal Year 2017 Milestones and Outlines 2018 Goals
REDWOOD CITY, Calif., April 03, 2018 (GLOBE NEWSWIRE) -- Biotricity Inc.  (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring solutions, today provided a progress update for the end of the 2017 f...
Source: GlobeNewswire
Date: April, 03 2018 08:00
Biotricity Appoints Casey Shattuck as New VP of Sales to Spearhead Bioflux Launch
REDWOOD CITY, Calif., March 13, 2018 (GLOBE NEWSWIRE) -- Biotricity Inc.  (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring solutions, today announced the company has appointed Mr. Casey Shattu...
Source: GlobeNewswire
Date: March, 13 2018 08:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-180.570.580.6150.5658,818
2018-12-170.620.600.680.5558,334
2018-12-140.684950.650250.684950.613540,040
2018-12-130.65990.671990.727450.6056,336
2018-12-120.900.640.900.55389,424

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1823,15058,81839.3587Short
2018-12-1715,36758,33426.3431Cover
2018-12-147,40040,04018.4815Cover
2018-12-138,65456,33615.3614Cover
2018-12-12100,276389,42425.7498Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on BTCY.


About Biotricity Inc. (OTC: BTCY)

Logo for Biotricity Inc. (OTC: BTCY)

Biotricity is a modern medical technology company focused on delivering innovative, remote biometric monitoring solutions to the medical and consumer markets, including diagnostic and post diagnostic solutions for chronic conditions and lifestyle improvement. To learn more, visit www.biotricity.com.

 

Contact Information

 

 

Current Management

  • Waqaas AlSiddiq / President, CEO
  • Tom Nelson / Advisory Director
  • John Rother / Advisory Director
  • Bernard Rice / Advisory Director
  • Danny Sands / Advisory Director
  • Nayyar Razvi / Advisory Director
  • David Liepert / Advisory Director
  • Waqaas AlSiddiq / Chairman
  • Norman Betts / Independent Director
  • Dave Rosa / Independent Director

Current Share Structure

  • Market Cap: $89,584,337 - 03/09/2018
  • Authorized: 125,000,000 - 02/05/2016
  • Issue and Outstanding: 23,268,659 - 02/12/2018
  • Float: 4,500,000 - 08/09/2016

 


Recent Filings from (OTC: BTCY)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 23 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 03 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 16 2018
Prospectus filed under Rule 424(b)(3)
Filing Type: 424B3Filing Source: edgar
Filing Date: March, 13 2018
Notice from the SEC of registration effectiveness
Filing Type: EFFECTFiling Source: edgar
Filing Date: March, 09 2018
Notice from the SEC of registration effectiveness
Filing Type: EFFECTFiling Source: edgar
Filing Date: March, 09 2018
Amendment to general form for registration of securities under the Securities Act of 1933
Filing Type: S-1/AFiling Source: edgar
Filing Date: March, 08 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 05 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: February, 14 2018
General form for registration of securities under the Securities Act of 1933
Filing Type: S-1Filing Source: edgar
Filing Date: February, 09 2018

 

 


Daily Technical Chart for (OTC: BTCY)

Daily Technical Chart for (OTC: BTCY)


Stay tuned for daily updates and more on (OTC: BTCY)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: BTCY)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in BTCY is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of BTCY and does not buy, sell, or trade any shares of BTCY. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/